FDA Approves Novavax’s COVID-19 Vaccine With Restrictions
On May 16, 2025, the U.S. Food and Drug Administration (FDA) approved licensure of Novavax, Inc.’s Nuvaxovid protein-based COVID-19 vaccine, which has been available in the United States under Emergency Use Authorization (EUA) since July 2022.1 The decision for a full licensure was postponed while the new agency leadership under the current administration conducted a […]
‘All New Vaccines’ in the U.S. to Undergo Placebo-Controlled Safety Testing
On Apr. 30, 2025, the U.S. Department of Health and Human Services (DHHS) announced that all newly developed vaccines will now be required to undergo placebo-controlled clinical trials before being licensed by the U.S. Food and Drug Administration (FDA). This landmark policy shift comes after years of advocacy from consumer organizations critical of vaccine safety […]
HHS Halts Funding for Development of Next-Generation COVID Biologics
The U.S. Department of Health and Human Services (DHHS) has stopped U.S. government funding for the development of next-generation COVID-19 biologics by two companies, GeoVax, Inc. of Atlanta, Georgia and CastleVax, Inc. of New York. The project had been funded by Project NextGen, a Biden administration initiative under the U.S. Center for the Biomedical Advanced […]
COVID-19 Shot Safety, Efficacy Concerns Exposed by Florida Grand Jury
While recent news headlines proclaim that a Florida Grand Jury has found no evidence of crimes committed by the manufacturers of COVID-19 shots, the actual report published earlier this month paints a more thorough picture. Two years after Florida’s Governor Ron DeSantis called for a federal investigation into the experimental mRNA COVID biologics for “any […]
COVID Shot Injury Claims Rarely Being Paid by U.S. Government
A report from the U.S. Government Accountability Office (GAO) showed that claims made under the Health and Human Services (HHS) Countermeasures Injury Compensation Program (CICP) during the first few years of the COVID-19 pandemic have risen 27 percent since the program started receiving claims in 2009. However, only three percent of the COVID shot injury […]
FDA Ordered to Release Data on Emergency Use Authorization of COVID-19 Shots
The U.S. Food and Drug Administration (FDA) has been ordered to disclose data it relied on when authorizing COVID-19 shots. U.S. District Court Judge Mark Pittman in Fort Worth, Texas ordered the FDA to release their file on “emergency use authorization” (EUA) related to the Pfizer/BioNTech Comirnaty COVID biologic to a group of scientists. Accordingly, […]